More than 60% of all cancer patients in Europe and the USA are older than 65 years at the time of diagnosis. Despite this, elderly patients are generally under-represented in clinical trials. There is a lack of clinical trials to drive evidence-based decision making in the elderly cancer patients.
In this review, we address the most important issue surrounding the treatment of older cancer patients: comorbidity assessment.Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
F. Fiorica, A. Stefanelli, R. Fisichella, U. Tirelli, M. Berretta
Comorbidity assessment and radiotherapy in elderly cancer patients
Eur Rev Med Pharmacol Sci
Vol. 16 - N. 11